J. Donadieu

P. Terrier, A. Barrier, A. Le Cesne, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000–2004

J. Donadieu, J. Clavel, S. Bellec, 2008, Pediatric blood & cancer.

B-Cell and T-Cell Phenotypes in CVID Patients Correlate with the Clinical Phenotype of the Disease

É. Oksenhendler, P. Debré, M. Morisset, 2010, Journal of Clinical Immunology.

Autoimmunity associated with Erdheim-Chester disease improves with BRAF/MEK inhibitors

J. Emile, Z. Amoura, F. Charlotte, 2019, Haematologica.

Expansion of Regulatory T Cells in Patients with Langerhans Cell Histiocytosis

A. Fischer, F. Geissmann, P. Josset, 2007, PLoS medicine.

ALK+ histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.

Michael M. Henry, F. Feuerhake, K. Ernestus, 2021, Blood.

Clinical spectrum of γδ+ T cell LGL leukemia: Analysis of 20 cases

T. Fest, R. Zambello, T. Loughran, 2008 .

CXCR4 signaling controls dendritic cell location and activation at steady-state and in inflammation.

L. Ng, Y. Bertrand, M. Evrard, 2021, Blood.

Thymus and Mediastinal Node Involvement in Childhood Langerhans Cell Histiocytosis: Long-Term Follow-Up From the French National Cohort

G. Leverger, J. Emile, C. Berger, 2013, Pediatric blood & cancer.

Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009

Y. Révillon, I. Pin, L. Boccon-Gibod, 2010, Orphanet journal of rare diseases.

ELANE neutropenia and solid tumors: Four cases from the French severe chronic neutropenia registry

L. Quéro, T. Leblanc, C. Bellanné-Chantelot, 2021, Pediatric blood & cancer.

Prevalence of vernal keratoconjunctivitis: a rare disease?

S. Aymé, S. Doan, T. Hoang‐Xuan, 2008, British Journal of Ophthalmology.

Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A.

F. Ledeist, C. Griscelli, J. Stéphan, 1993, Blood.

Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A

F. Ledeist, C. Griscelli, J. Stéphan, 1993 .

Complications and treatment of patients with β-thalassemia in France: results of the National Registry

B. Pégourié, T. Leblanc, C. Berger, 2010, Haematologica.

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study).

K. Hoang-Xuan, F. Carrat, A. Idbaih, 2017, Blood.

Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelines

T. Leblanc, L. Claude, O. Oberlin, 2016, Pediatric hematology and oncology.

Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry

F. Jardin, T. Leblanc, Y. Bertrand, 2009, Pediatric blood & cancer.

Efficacy of dupilumab for controlling severe atopic dermatitis with dominant‐negative CARD11 variant

C. Bellanné-Chantelot, M. Bagot, J. Donadieu, 2021, Clinical and experimental dermatology.

antithymocyte globulins, steroids, and cyclosporin A Treatment of familial hemophagocytic lymphohistiocytosis with

F. Ledeist, C. Griscelli, J. Stéphan, 2011 .

of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome.

Y. Bertrand, J. Donadieu, O. Fenneteau, 2012 .

High frequency of GATA 2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome , myelodysplasia , and acute myeloid leukemia *

P. Rohrlich, C. Ferrand, C. Bellanné-Chantelot, 2013 .

STEM CELL TRANSPLANTATION IN PATIENTS AFFECTED BY SHWACHMAN- DIAMOND SYNDROME: EXPERT CONSENSUS AND RECOMMENDATIONS FROM THE EBMT SEVERE APLASTIC ANAEMIA WORKING PARTY.

M. Aljurf, R. Masetti, C. Dufour, 2022, Transplantation and cellular therapy.

Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study

K. Hoang-Xuan, C. Garel, A. Idbaih, 2011, Orphanet journal of rare diseases.

Draft consensus guidelines for diagnosis and treatment of Shwachman‐Diamond syndrome

J. Rommens, T. Kuijpers, Johnson M Liu, 2011, Annals of the New York Academy of Sciences.

Clinical trials in childhood acute lymphoblastic leukemia: a common prognostic classification and a common induction therapy are now warranted.

J. Donadieu, C. Hill, 2002, Journal of pediatric hematology/oncology.

Register neutropenia: A study of 81 patients from the French Neutropenia Mutations in the ELA2 gene correlate with more severe expression of

T. Leblanc, C. Bellanné-Chantelot, S. Beaufils, 2013 .

Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.

É. Oksenhendler, W. Vainchenker, T. Leblanc, 2018, Blood.

A European phase II study of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children

J. Donadieu, N. Philippe, P. Boutard, 1997, European Journal of Pediatrics.

The international dataset on the association between Langerhans Cell Histiocytosis and other malignancies

S. Zimmermann, R. Haupt, J. Donadieu, 2022, Data in brief.

Peritoneal or mesenteric tumours revealing histiocytosis

J. Emile, J. Selves, F. Charlotte, 2021, BMJ Open Gastroenterology.

All trans retinoic acid abrogates spontaneous monocytic growth in juvenile chronic myelomonocytic leukaemia.

A. Baruchel, P. Rohrlich, C. Chomienne, 2001, The hematology journal : the official journal of the European Haematology Association.

Augmented post-induction therapy in childhood lymphoblastic leukemia.

J. Donadieu, C. Hill, 1998, The New England journal of medicine.

How to differentiate congenital from noncongenital chronic neutropenia at the first medical examination? Proposal of score: A pilot study from the French Severe Chronic Neutropenia registry

C. Bellanné-Chantelot, Y. Bertrand, J. Donadieu, 2017, Pediatric blood & cancer.

Tetralogy of Fallot is an Uncommon Manifestation of Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome

L. Dotta, R. Badolato, F. Locatelli, 2012, The Journal of pediatrics.

Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease

P. Cluzel, J. Emile, Z. Amoura, 2018, Arteriosclerosis, thrombosis, and vascular biology.

B – helper neutrophils stimulate immunoglobulin diversification and production in the marginal zone of the spleen

S. Serrano, J. Lloreta, J. Casanova, 2016 .

Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations

L. Faivre, C. Bellanné-Chantelot, F. Bachelerie, 2016, Journal of leukocyte biology.

Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease.

A. Fischer, C. Griscelli, J. Levron, 1994, The Journal of pediatrics.

Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia.

J. Emile, C. Chomienne, J. Donadieu, 2002, Blood.

Shwachman‐Diamond syndrome and solid tumors: Three new patients from the French Registry for Severe Chronic Neutropenia and literature review

D. Blaise, C. Bellanné-Chantelot, F. Delhommeau, 2021, Pediatric blood & cancer.

TP53 mutations: the dawn of Shwachman clones.

F. Delhommeau, J. Donadieu, 2018, Blood.

Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents.

C. Garel, M. Polak, J. Donadieu, 2011, The Journal of clinical endocrinology and metabolism.

Is G‐CSF‐mobilized peripheral stem cell harvest harmful?

J. Donadieu, 2007, Pediatric blood & cancer.

[Cutaneous manifestations disclosing T-cell gamma/delta lymphoma in a 13-year-old-girl].

C. Bodemer, P. Agache, C. Griscelli, 1993, Annales de dermatologie et de venereologie.

Post‐COVID‐19 severe neutropenia

C. Bellanné-Chantelot, S. Héritier, J. Donadieu, 2020, Pediatric blood & cancer.

Long‐term efficacy and safety of 2CdA (cladribine) in extra‐pulmonary adult‐onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review

C. Dromer, O. Hermine, A. Néel, 2020, British journal of haematology.

Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.

Y. Bertrand, J. Donadieu, C. Vermylen, 2005, European journal of cancer.

Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance

J. Casanova, L. F. Jobim, C. Deswarte, 2021, Journal of Clinical Immunology.

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia

C. Ferrand, J. Corre, E. Delabesse, 2017 .

Highly sensitive methods are required to detect mutations in histiocytoses

M. Copin, J. Emile, Z. Amoura, 2018, Haematologica.

Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register

A. Fischer, T. Leblanc, E. Gluckman, 2005, Bone Marrow Transplantation.

Response to trametinib of histiocytosis with an activating PTPN11 mutation

J. Emile, J. Haroche, J. Donadieu, 2020, Leukemia & lymphoma.

2′‐chlorodeoxyadenosine (2‐CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH‐S‐98 protocol of the histiocyte society

R. Arceci, J. Whitlock, U. Pötschger, 2009, Pediatric blood & cancer.

Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry

A. Fischer, J. Casanova, G. Leverger, 2005, Bone Marrow Transplantation.

FranceCoag Network: A National Multicenter Prospective Cohort for Congenital Bleeding Disorders.

T. Lambert, É. Fressinaud, V. Guérin, 2005 .

Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.

V. Meignin, J. Emile, L. Arnaud, 2014, Blood.

Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry

P. Rohrlich, A. Dupuy, Y. Bertrand, 2012, Orphanet Journal of Rare Diseases.

Langerhans Cell Histiocytosis (LCH): Guidelines for Diagnosis, Clinical Work-Up, and Treatment for Patients Till the Age of 18 Years

C. Rodríguez-Galindo, R. Egeler, S. V. Van Gool, 2012, Pediatric blood & cancer.

Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients.

A. Fischer, C. Griscelli, A. Durandy, 1993, The Journal of pediatrics.

Sweet Syndrome as the Presenting Manifestation of Chronic Granulomatous Disease in an Infant

C. Lebbé, J. Donadieu, P. Labrune, 1994, Pediatric dermatology.

Epigenetic Regulation of Protein-Coding and MicroRNA Genes by the Gfi1-Interacting Tumor Suppressor PRDM5

Zhijun Duan, H. Leighton Grimes, Hu-Hui Lee, 2007, Molecular and Cellular Biology.

Medical management of langerhans cell histiocytosis from diagnosis to treatment

F. Chalard, J. Donadieu, E. Jeziorski, 2012, Expert opinion on pharmacotherapy.

Revised Classification of Histiocytoses and Neoplasms of the Macrophage-dendritic Cell Lineages Histiocyte and Dendritic Cell Lineages the " L " (langerhans) Group

A. Fischer, B. Rollins, O. Abdel-Wahab, 2022 .

Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification.

U. Pötschger, R. McCarter, H. Gadner, 2008, Blood.

Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French severe congenital neutropenia registry

C. Picard, M. Frémond, J. Bruneau, 2014, Orphanet Journal of Rare Diseases.

Prevention of infections during primary immunodeficiency.

A. Fischer, C. Picard, É. Oksenhendler, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report.

Laurence Boxer, M. Freedman, K. Welte, 2006, Supportive cancer therapy.

Incidence des radiodermites secondaires à un geste de radiologie interventionnelle

C. Roudier, P. Pirard, J. Donadieu, 2006 .

Detection of GM‐CSF in the sera of children with Langerhans’ cell histiocytosis

A. Fischer, E. Tartour, W. Fridman, 1994, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

Bertrand Joly, Olivier Hermine, Thierry Lamy, 2005, Haematologica.

BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.

Valérie Rigau, Valérie Taly, Christine Bodemer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome.

R. Badolato, J. Donadieu, 2017, Blood.

Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history

C. Bellanné-Chantelot, J. Donadieu, O. Fenneteau, 2017, British journal of haematology.

Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutations

C. Bellanné-Chantelot, S. Beaufils, J. Donadieu, 2014, Pediatric blood & cancer.

Somatic genetic rescue of a germline ribosome assembly defect

P. Revy, A. Warren, P. Bond, 2021, Nature Communications.

EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome.

P. Revy, A. Warren, C. Bole-Feysot, 2019, Blood.

Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia

J. Stéphan, C. Berger, J. Donadieu, 2005, Bone Marrow Transplantation.

Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort

A. Servais, P. de Lonlay, B. Pigneur, 2020, Molecular genetics and metabolism reports.

No association between Langerhans cell histiocytosis and human herpes virus 8.

F. Geissmann, N. Brousse, A. Gessain, 2002, Medical and pediatric oncology.

New somatic BRAF splicing mutation in Langerhans cell histiocytosis

C. Bellanné-Chantelot, J. Emile, A. Moreau, 2017, Molecular Cancer.

Histiocytoses: emerging neoplasia behind inflammation.

B. Rollins, O. Abdel-Wahab, A. Idbaih, 2017, The Lancet. Oncology.

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.

B. Taylor, P. Stephens, J. Baselga, 2016, Cancer discovery.

Cumulative Effective Doses Delivered by Radiographs to Preterm Infants in a Neonatal Intensive Care Unit

Catherine Adamsbaum, Gabriel Kalifa, A. Zeghnoun, 2006, Pediatrics.

Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: a methodological review

J. Donadieu, C. Hill, Jean Donadieu, 2001, British journal of haematology.

Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)

A. Baruchel, G. Leverger, C. Hill, 2000, British Journal of Cancer.

Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables

A. Baruchel, G. Leverger, T. Leblanc, 1998, British journal of haematology.

arising in the setting of severe congenital neutropenia Distinct patterns of mutations occurring in de novo AML versus AML

E. Mardis, C. Bloomfield, M. McLellan, 2013 .

Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.

R. Wilson, E. Mardis, M. Caligiuri, 2007, Blood.

Histiocytosis

B. Rollins, O. Abdel-Wahab, A. Idbaih, 2021, The Lancet.

Massive splenomegaly and pancytopenia reuealing sarcoidosis in a child.

R. Epaud, A. Clément, A. Coulomb, 2013, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Application of whole‐exome sequencing to unravel the molecular basis of undiagnosed syndromic congenital neutropenia with intellectual disability

J. Melki, J. Rivière, J. Thevenon, 2017, American journal of medical genetics. Part A.

Premature Ovarian Insufficiency in CLPB Deficiency: Transcriptomic, Proteomic and Phenotypic Insights

A. Sinclair, S. Rahman, S. Wortmann, 2022, The Journal of clinical endocrinology and metabolism.

Correction: Corrigendum: B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

S. Serrano, J. Lloreta, J. Casanova, 2014, Nature Immunology.

Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study

A. Idbaih, M. Golan, J. Emile, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Rosai-Dorfman disease: Diagnosis and therapeutic challenges].

J. Emile, Z. Amoura, N. Schleinitz, 2018, La Revue de medecine interne.

Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance

J. Casanova, L. F. Jobim, C. Deswarte, 2021, Journal of Clinical Immunology.

Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis

Baptiste N. Jaeger, M. Bajénoff, B. Malissen, 2012, The Journal of experimental medicine.

Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease.

O. Abdel-Wahab, D. Hyman, K. Leroy, 2014, Blood.

Long‐term follow‐up of children with risk organ‐negative Langerhans cell histiocytosis after 2‐chlorodeoxyadenosine treatment

G. Leverger, J. Emile, P. Schneider, 2020, British journal of haematology.

associated with therapy intensification Improved outcome in multisystem Langerhans cell histiocytosis is

U. Pötschger, R. McCarter, H. Gadner, 2013 .

Renal carcinoma in a patient with glycogen storage disease Ib receiving long-term granulocyte colony-stimulating factor therapy.

Y. Bertrand, J. Donadieu, C. Pondarré, 2000, Journal of pediatric hematology/oncology.

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.

U. Pötschger, H. Gadner, M. Aricò, 2013, Blood.

Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome

T. Leblanc, C. Bellanné-Chantelot, S. Beaufils, 2012, Haematologica.

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

M. Copin, A. von Deimling, N. Brousse, 2012, Blood.

B-RAF Mutant Alleles Associated with Langerhans Cell Histiocytosis, a Granulomatous Pediatric Disease

F. Fraternali, G. Mufti, F. Geissmann, 2012, PloS one.

Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans Cell Histiocytosis.

A. Idbaih, P. Touraine, Z. Amoura, 2019, European journal of endocrinology.

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study

K. Hoang-Xuan, G. Leverger, A. Idbaih, 2018, British journal of haematology.

[Neuro-Langerhans cell histiocytosis].

K. Hoang-Xuan, É. Bayen, A. Del Cul, 2017, Presse medicale.

Correction: B-RAF Mutant Alleles Associated with Langerhans Cell Histiocytosis, a Granulomatous Pediatric Disease

F. Fraternali, G. Mufti, F. Geissmann, 2012, PLoS ONE.

cell histiocytosis Therapy prolongation improves outcome in multisystem Langerhans

M. Aricò, G. Janka-Schaub, J. Donadieu, 2013 .

Genetics of severe congenital neutropenia as a gateway to personalized therapy.

C. Bellanné-Chantelot, J. Donadieu, 2022, Hematology. American Society of Hematology. Education Program.

Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.

P. Grenier, P. Cluzel, A. Idbaih, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A single‐centre study can improve our knowledge of a rare disease! As exemplified by studies in Langerhans' cell histiocytosis

J. Donadieu, 2005, Acta paediatrica.

The importance of rare diseases: from the gene to society

Arunas Valiulis, Zachi Grossman, Feliciano Ramos, 2010, Archives of Disease in Childhood.

Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age

K. Hoang-Xuan, J. Emile, Y. Bertrand, 2016, British journal of haematology.

Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.

M. V. van Noesel, M. Aricò, J. Donadieu, 2015, Blood.

Langerhans' cell histiocytosis of the liver in adults.

J. Emile, O. Chazouilleres, C. Gaujoux-Viala, 2011, Clinics and research in hepatology and gastroenterology.

Retinoic acid therapy in “degenerative‐like” neuro‐langerhans cell histiocytosis: A prospective pilot study

K. Hoang-Xuan, A. Idbaih, F. Geissmann, 2004, Pediatric blood & cancer.

Reproductive toxicology. Ethylene glycol monomethyl ether: litter two.

A. Fischer, F. Geissmann, P. Josset, 1997, Environmental health perspectives.

A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.

J. Schuurs-Hoeijmakers, M. Reijnders, H. Brunner, 2018, American journal of human genetics.

Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: a Cooperative Study of the Société Française de Greffe de Moelle.

J. Donadieu, F. Bernaudin, F. Demeocq, 1995, Bone marrow transplantation.

Epidemiology of congenital neutropenia.

C. Bellanné-Chantelot, N. Mahlaoui, J. Donadieu, 2013, Hematology/oncology clinics of North America.

Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases

T. Fest, O. Reman, J. Rey, 2010, Haematologica.

Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register.

Fernando Rodrigues-Lima, Mohamed Barkaoui, Christine Chomienne, 2004, Blood.

Biallelic CXCR2 loss-of-function mutations define a distinct congenital neutropenia entity

T. Leblanc, C. Bellanné-Chantelot, F. Bachelerie, 2021, Haematologica.

Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation.

A. Fischer, A. Baruchel, M. Cavazzana‐Calvo, 1994, Bone Marrow Transplantation.

MRI features of intra-axial histiocytic brain mass lesions.

K. Hoang-Xuan, D. Galanaud, D. Dormont, 2020, Clinical radiology.

Severe chronic primary neutropenia in adults: report on a series of 108 patients.

É. Oksenhendler, P. Moreau, C. Bellanné-Chantelot, 2015, Blood.

Recurrent bacterial infections, but not fungal infections, characterise patients with ELANE‐related neutropenia: a French Severe Chronic Neutropenia Registry study

T. Leblanc, C. Bellanné-Chantelot, S. Blanche, 2021, British journal of haematology.

HSCT may lower leukemia risk in ELANE neutropenia: a before–after study from the French Severe Congenital Neutropenia Registry

C. Bellanné-Chantelot, Y. Bertrand, B. Neven, 2020, Bone Marrow Transplantation.

PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms

S. Corey, S. Salipante, H. Grimes, 2014 .

Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis.

A. Fischer, C. Picard, E. Macintyre, 2011, The Journal of allergy and clinical immunology.

Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants.

A. Fischer, J. Stéphan, J. Wijdenes, 1994, Bone marrow transplantation.

Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor.

J. Donadieu, S. Kinsey, C. Fier, 2002, Seminars in hematology.

Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes

F. Locatelli, M. Wlodarski, J. Wachowiak, 2015, Bone Marrow Transplantation.

Identification of biallelic germline variants of SRP68 in a sporadic case with severe congenital neutropenia

C. Bellanné-Chantelot, J. Donadieu, I. Plo, 2020, Haematologica.

Congenital and Acquired Chronic Neutropenias: Challenges, Perspectives and Implementation of the EuNet-INNOCHRON Action

J. Palmblad, K. Stamatopoulos, C. Mecucci, 2020, HemaSphere.

Histiocytic Disorders of Children and Adults: Langerhans cell histiocytosis: a clinical update

R. Egeler, J. Donadieu, J. Pritchard, 2005 .

Neutropenia-Associated Mutations in PRDM5, a Novel Epigenetic Regulator of Hematopoiesis.

R. Badolato, R. Person, Z. Duan, 2006 .

Update On the Risk of Leukemia in Genetic Subgroups of Congenital Neutropenia (CN): Comparison of Patients with Known Gene Mutations (ELA2, HAX1, WASP, G6PC3, p14).

C. Klein, D. Link, K. Welte, 2009 .

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency

F. Rieux-Laucat, A. Fischer, J. Jais, 2019, Journal of Clinical Immunology.

A New clinical score for disease activity in Langerhans cell histiocytosis

Y. Bertrand, O. Hermine, J. Donadieu, 2004, Pediatric blood & cancer.

Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment.

C. Garel, M. Polak, F. Doz, 2004, The Journal of clinical endocrinology and metabolism.

Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: Experience of the French Langerhans Cell Study Group

J. Casanova, Y. Bertrand, S. Blanche, 2003, Bone Marrow Transplantation.

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

F. Rieux-Laucat, A. Fischer, J. Jais, 2017, The Journal of allergy and clinical immunology.

Hemophagocytic Lymphohistiocytosis and Diagnostic Difficulties

C. Picard, D. Moshous, J. Donadieu, 2019, GMJ Medicine.

Early-onset hypogammaglobulinemia: A survey of 44 patients.

F. Rieux-Laucat, A. Fischer, C. Picard, 2015, The Journal of allergy and clinical immunology.

Neutropenia in Patients with Common Variable Immunodeficiency: a Rare Event Associated with Severe Outcome

F. Rieux-Laucat, É. Oksenhendler, S. Hanein, 2017, Journal of Clinical Immunology.

Lung involvement in Destombes-Rosai-Dorfman disease: clinical and radiological features and response to the MEK inhibitor cobimetinib.

P. Grenier, P. Maksud, J. Emile, 2020, Chest.

Heterozygous Variants of CLPB are a Cause of Severe Congenital Neutropenia.

D. Spencer, D. Link, A. Locke, 2021, Blood.

PTPN11 mutations in canine and human disseminated histiocytic sarcoma

T. Derrien, J. Blay, C. Copie-Bergman, 2020, International journal of cancer.

Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study

S. Chevret, V. Cottin, A. Aouba, 2017, Orphanet Journal of Rare Diseases.

Cutaneous adverse events in children treated with vemurafenib for refractory BRAFV600E mutated Langerhans cell histiocytosis

J. Emile, F. Boralevi, J. Donadieu, 2021, Pediatric blood & cancer.

Vemurafenib Use in an Infant for High-Risk Langerhans Cell Histiocytosis.

G. Leverger, J. Emile, S. Héritier, 2015, JAMA oncology.

Cholesteatoma Secondary to Temporal Bone Involvement by Langerhans Cell Histiocytosis: A Complication Amenable to Curative Surgery

J. Donadieu, P. Bordure, B. Godey, 2009, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Intermittent chronic neutropenia in a patient with familial Mediterranean fever

F. Ailal, C. Bellanné-Chantelot, J. Donadieu, 2008, Pediatric blood & cancer.

Phenotypes and survival in Erdheim‐Chester disease: Results from a 165‐patient cohort

P. Cluzel, F. Carrat, A. Idbaih, 2018, American journal of hematology.

Management of Gorham Stout disease with skull-base defects: Case series of six children and literature review.

F. Denoyelle, F. Simon, R. Khonsari, 2019, International journal of pediatric otorhinolaryngology.

Main clinical, therapeutic and technical factors related to patient's maximum skin dose in interventional cardiology procedures.

S. Sinno-tellier, D. Eilstein, A. Le Tertre, 2012, The British journal of radiology.

Chest computed tomography findings for a cohort of children with pulmonary Langerhans cell histiocytosis

H. Brisse, R. Epaud, H. Ducou le Pointe, 2020, Pediatric blood & cancer.

E. Bosdure, N. Stremler, P. Petit, 2018, Pediatric blood & cancer.

Clinical spectrum of gammadelta+ T cell LGL leukemia: analysis of 20 cases.

T. Fest, R. Zambello, T. Loughran, 2008, Leukemia research.

Neutropenia in congenital nephrotic syndrome of the Finnish type: role of urinary ceruloplasmin loss.

A. Bensman, J. Donadieu, T. Ulinski, 2009, Blood.

Distinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report

S. Sanjad, J. Donadieu, T. Ulinski, 2018, Journal of Medical Case Reports.

High doses of deferiprone may be associated with cerebellar syndrome

J. Donadieu, F. Beau-Salinas, E. Autret‐Leca, 2009, BMJ : British Medical Journal.

A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.

J. Schuurs-Hoeijmakers, M. Reijnders, H. Brunner, 2018, American journal of human genetics.

Estimation of the radiation dose from thoracic CT scans in a cystic fibrosis population.

C. Roudier, J. Donadieu, Jean Donadieu, 2007, Chest.

Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib

K. Hoang-Xuan, D. Galanaud, A. Idbaih, 2014, Neurology.

[Clinical presentation and epidemiology of childhood Langerhans cell Histiocytosis].

J. Donadieu, A. Guyot-Goubin, C. Thomas, 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

The cognitive spectrum in neurodegenerative Langerhans cell histiocytosis

K. Hoang-Xuan, R. Levy, É. Bayen, 2014, Journal of Neurology.

Neurodegeneration in histiocytoses might start in utero

J. Emile, Z. Amoura, F. Cohen-Aubart, 2017, Lancet Neurology.

A retrospective single-center study of clinical presentation and outcome in 117 patients with severe combined immunodeficiency.

A. Fischer, C. Griscelli, A. Durandy, 1993, Immunodeficiency.

New somatic BRAF splicing mutation in Langerhans cell histiocytosis

C. Bellanné-Chantelot, J. Emile, A. Moreau, 2017, Molecular Cancer.

Molecular and clinicopathologic characterization of pediatric histiocytoses

C. Bodemer, A. Idbaih, J. Emile, 2023, American journal of hematology.

Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis

A. Idbaih, Jacques Young, C. Vigouroux, 2019, Case reports in endocrinology.

Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAFV600E mutation study from the French national cohort.

M. Copin, J. Bernaudin, F. Paraf, 2019, Human pathology.

[Chronic septic granulomatosis revealed by neonatal pulmonary aspergillosis].

Y. Révillon, F. Brunelle, J. Donadieu, 1995, Archives de pédiatrie.

Establishment of MOS-SF36 percentile ranks in the general youth French population

J. Donadieu, B. Beaupain, M. Musiol, 2022, BMC psychology.

Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register

T. Leblanc, C. Bellanné-Chantelot, B. Bader-Meunier, 2004, Leukemia.

Central nervous system involvement in Erdheim-Chester disease

K. Hoang-Xuan, D. Galanaud, A. Idbaih, 2020, Neurology.

Somatic genetic alterations predict hematological progression in GATA2 deficiency

C. Bellanné-Chantelot, F. Delhommeau, I. Luquet, 2023, Haematologica.

Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis.

C. Rodríguez-Galindo, U. Pötschger, J. Donadieu, 2021, Jornal de Pediatria.

Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood

U. Pötschger, E. Glogova, H. Gadner, 2015, British journal of haematology.

Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis

B. Morland, C. Rodríguez-Galindo, J. Pears, 2022, Blood advances.

A circulating subset of BRAFV600E‐positive cells in infants with high‐risk Langerhans cell histiocytosis treated with BRAF inhibitors

F. Delhommeau, J. Emile, S. Héritier, 2021, British journal of haematology.

Langerhans Cell Histiocytosis and the Central Nervous System in Childhood: Evolution and Prognostic Factors. Results of a Collaborative Study

J. Donadieu, M. Barthez, Elizabeth Araujo, 2000, Journal of child neurology.

PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte‐rich tumours

J. Emile, S. Héritier, F. Cohen-Aubart, 2023, Histopathology.

Cardiomyopathies and congenital heart diseases in Shwachman-Diamond syndrome: a national survey.

J. Lethor, F. Gottrand, C. Bellanné-Chantelot, 2013, International journal of cardiology.

Langerhans cell histiocytosis and associated malignancies: A retrospective analysis of 270 patients.

S. Zimmermann, R. Haupt, J. Donadieu, 2022, European journal of cancer.

Recombinant human G-CSF (Lenograstim) for infectious complications in glycogen storage disease type Ib. Report of 7 cases.

Y. Bertrand, A. Yver, B. Bader-Meunier, 1994, Nouvelle revue francaise d'hematologie.

Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim

J. Donadieu, B. Beaupain, F. Rety-Jacob, 2009, Haematologica.

Prognostic impact of pulmonary nodules diagnosed at initial presentation in patients with osteosarcoma

S. Piperno-Neumann, S. Sarnacki, L. Brugières, 2022, Pediatric blood & cancer.

[Congenital and acquired neutropenia in children].

J. Donadieu, 1996, Presse medicale.

A phase II study of recombinant human granulocyte-colony stimulating factor (rHuG-CSF, lenograstim) in the treatment of agranulocytosis in children.

J. Donadieu, N. Philippe, E. Gordon-Smith, 1994, Nouvelle revue francaise d'hematologie.

Vemurafenib as first line therapy in BRAF-mutated Langerhans cell histiocytosis.

J. Emile, Z. Amoura, F. Cohen-Aubart, 2015, Journal of the American Academy of Dermatology.

Severe Transitory Neonatal Neutropenia Associated with Maternal Autoimmune or Idiopathic Neutropenia

J. Harlé, M. Ebbo, N. Schleinitz, 2019, Journal of Clinical Immunology.

A familial T-cell lymphoma with gamma delta phenotype and an original location. Possible role of chronic Epstein-Barr virus infection.

S. Schraub, C. Bodemer, F. Sigaux, 1996, Cancer.

Update of the French LGL Proliferation Registry : Report of 229 Cases

O. Reman, J. Rey, O. Tournilhac, 2009 .

RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation

C. Deswarte, E. Lippert, C. Demur, 2012, Leukemia.

[Langerhans cell histiocytosis in adults].

A. Néel, J. Donadieu, M. Artifoni, 2015, La Revue de medecine interne.

18F-FDG PET in neurodegenerative Langerhans cell histiocytosis

K. Hoang-Xuan, Y. Samson, P. Remy, 2008, Journal of Neurology.

Authors’ Response: Timing of Pituitary Stalk Assessment in Langerhans Cell Histiocytosis: “When” Is Sometimes More Important than “What”

M. Polak, J. Donadieu, 2004 .

Eye movement abnormalities in neurodegenerative langerhans cell histiocytosis

K. Hoang-Xuan, B. Gaymard, É. Bayen, 2022, Neurological Sciences.

Neutropenia in Patients with Common Variable Immunodeficiency: a Rare Event Associated with Severe Outcome

F. Rieux-Laucat, É. Oksenhendler, S. Hanein, 2017, Journal of Clinical Immunology.

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

A. Fischer, B. Rollins, O. Abdel-Wahab, 2016, Blood.

High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.

P. Rohrlich, C. Ferrand, C. Bellanné-Chantelot, 2013, Blood.

Loic Le GuennecCaroline DecaixJean DonadieuMaria Santiago-Ribeiro • Nadine Martin-DuverneuilRichard LevyDaniel DelgadilloAurelie KasAurelie Drier • Laurent MagyEleonore BayenKhe Hoang-XuanAhmed Idbaih

K. Hoang-Xuan, É. Bayen, A. Idbaih, 2014 .

OCT2 expression in histiocytoses

J. Emile, S. Héritier, F. Charlotte, 2023, Virchows Archiv.

Expansion of Regulatory T Cells in Patients with Langerhans Cell Histiocytosis

A. Fischer, F. Geissmann, P. Josset, 2007, PLoS medicine.

Long-term outcome of severe paediatric pulmonary Langerhans cell histiocytosis: do not underestimate lung plasticity

J. Donadieu, A. Tazi, A. Benattia, 2021, BMJ Case Reports.

Comment on “Subcutaneous administration of cytarabine for pediatric patients with Langerhans cell histiocytosis decreases burden of patient travel and infusion center utilization”

J. Donadieu, 2023, Pediatric blood & cancer.